ClinConnect ClinConnect Logo
Search / Trial NCT00424619

A Randomised, Controlled Comparison of Vitamin D Strategies is Acute Hip Fracture Patients

Launched by MCMASTER UNIVERSITY · Jan 17, 2007

Trial Information

Current as of September 23, 2025

Completed

Keywords

Vitamin D Hip Fracture Optimal Level Deficiency Functional Muscle Strength

ClinConnect Summary

Low Vitamin D levels can cause faster bone loss and increase the risk of having a fracture. Patients who experience a hip fracture have low levels of Vitamin D. It is not clear how much Vitamin D must be taken in order to reach this optimal level.

Serum 25-hydroxyvitamin D3 (25-OHD) concentrations are the recognized functional status indicator for vitamin D. Although there is no clear consensus, vitamin D 'insufficiency' has been considered in the range of 25- 75/80 nmol/L. Patients with acute hip fracture are at high risk for a recurrent hip fracture or other fragility fractures (and fall...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Fragility hip fracture patient
  • Previous Vitamin D supplementation is okay.
  • Exclusion Criteria:
  • Patients with pathological fracture secondary to malignancy or intrinsic bone disease (eg. Paget's disease)
  • Cancer in the past 10 years likely to metastasize to bone
  • Renal insufficiency (creatinine \<30 mls/min)
  • Hypercalcemia (primary hyperparathyroidism; granulomatous diseases; drug-induced such as lithium, thiazides), hypocalcemia, hypercalciuria, fracture or stroke within the last 3 months
  • Hormone replacement therapy, calcitonin, fluoride, or bisphosphonates during the previous 24 months
  • Pre-existing bone abnormality
  • Renal stones in past 10 years

About Mcmaster University

McMaster University, a leading research institution located in Hamilton, Ontario, Canada, is renowned for its innovative approach to education and its commitment to advancing healthcare through rigorous clinical research. The university's diverse research programs are supported by a multidisciplinary team of experts dedicated to improving patient outcomes and public health. With a strong emphasis on evidence-based medicine, McMaster University actively engages in clinical trials that explore new therapies, interventions, and health technologies, fostering collaboration among researchers, healthcare professionals, and industry partners to translate findings into real-world applications.

Locations

Patients applied

0 patients applied

Trial Officials

Alexandra Papaioannou, M.D., M.Sc.

Principal Investigator

McMaster University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials